How about you try again? 2000 devices reported in MAUDE out of about 80,000 sold. That's an unacceptable failure rate for a Class III medical device. The clock is ticking, tick tock, tick tock...........
I am very familiar with maude. prior to posting this message the maude data base is exactly what I had searched.
Thank you for calling me a little boy.
Thank you for calling me incompetent.
Thank you for calling me uneducated.
You don't know me!!!! Why must you call me names???? Are you that unhappy of a short????
Again I find in the maude data base plenty of Medtronic issues for the sprint fidelis issue and that is a class 1 recall.
What you are speaking of is not!!!
What I also find is plenty of oversensing issues and things of that nature. All are very inherent issues of trying to sense a heart beat through an insulated metal wire.
BSX does far better in the oversensing issue then Medtronic has ever done. For some reason Medtronic can never get its far field sensing issue right. They sense atrial activity on the ventricular lead.
That is what I am finding in the MAUDE. I search all.
Please try again
Since you're totally incompetent and uneducated, let me show you where to find it little boy:
Go to this website:
Type in Cognis for Brand Name and leave everything else blank, adjust date from 01/01/2009 to 12/31/2009 and search
After reading the Cognis reports, go back to the search page and type in Teligen for brand name and leave everything else blank, and make sure date ranges are same
Not trying to defend anything. Can't find anything that shows the numbers your talking about what I did find is a whole lot (as in tens of thousands on Medtronic Sprint fidelis lead issues) WHich is a class 1 recall why don't you go to their message board. That is where the real device issue is.
Nothing man made is perfect.
Try again please
Nobody will acquire them, they have $12 billion in liabilities on the books, their revenues from their bread and butter divisions DES and CRM are sinking worldwide due to pricing pressures and shoddy quality, and they suffer from balance sheet insolvency.
Yes, they are in a good industry, and a better buy in this industry would be STJ, MDT, ABT, BCR, or JNJ. With the exception of STJ, the others all pay a dividend on their shares.
funny coming from someone that owns a sack full of this stock. You bash the stock but yet own a ton of it and are accumulating as much as you can at these price. I can see why your motive would be pessimist, accumulate as many shares possible before lift off and try not to put any buying pressure on it. good job!!!!!
So the facts of offering 2 clearly different drugs on drug eluting stents.
Having done the most clinical trials in the industry to expand use of CRM devices (80% of all devices all companies are implanted do to trials done by BSX CRM) Continuing this level of R and D. Has nothing to do with how this company will function in the future????
Good luck shorting till bankrupt